Related Experiment Video
Updated: Apr 5, 2026

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
Lead User Design: Medication Management in Electronic Medical Records
Morgan Price1, Jens H Weber1, Iryna Davies2
1Dept. of Computer Science, University of Victoria, Victoria, British Columbia, BC, Canada.
Abstract:
Improvements in medication management may lead to a reduction of preventable errors. Usability and user experience issues are common and related to achieving benefits of Electronic Medical Records (EMRs). This paper reports on a novel study that combines the lead user method with a safety engineering review to discover an innovative design for the medication management module in EMRs in primary care. Eight lead users were recruited that represented prescribers and clinical pharmacists with expertise in EMR design, evidence-based medicine, medication safety and medication research. Eight separate medication management module designs were prototyped and validated, one with each lead user. A parallel safety review of medicaiton management was completed. The findings were synthesized into a single common set of goals, activities and one interactive, visual prototype. The lead user method with safety review proved to be an effective way to elicit diverse user goals and synthesize them into a common design. The resulting design ideas focus on meeting the goals of quality, efficiency, safety, reducing the cognitive load on the user, and improving communication wih the patient and the care team. Design ideas are being adapted to an existing EMR product, providing areas for further work.
More Related Videos
Related Concept Videos
Methods of Documentation VII: EMR
Dosage Regimens: Designs and Approaches
Dosage Regimen Designs: Nomograms and Tabulations
Drug Dosing: Geriatric Patients
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...

